Suppr超能文献

CD117免疫阳性的小肠间质瘤中Ki67和p53蛋白的预后意义

[Prognostic significance of Ki67 and p53 protein in small bowel stromal tumor immunopositive for CD117].

作者信息

Liu Ping, Na Jia, Zhang Jianbo, Zhang Ying

机构信息

Department of Pathology, Peking University First Hospital, Beijing 100034, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Feb 18;35(1):28-32.

Abstract

OBJECTIVE

To investigate the correlative factors of the prognosis by observing the immunohistochemical features of small bowel stromal tumors(SBST).

METHODS

Thirty-three cases of stromal tumors with expressed CD117 were examined by the light microscope. The expressions of Ki67 and p53 protein with EnVision + staining were detected in the tumors and compared with the morphology.

RESULTS

The group included 20 males and 13 females whose ages ranged from 21 to 71 years (median: 46 years); the tumors were situated in duodenum (5 cases), jejunum (22 cases) and ileum (6 cases). Grossly, tumors size was from 1.5 to 20 cm. In eleven cases tumors showed foci of tumor cell necroses. In all these cases, mitotic counts ranged from 0 to 62 mitotic figures per 50 HPF (high-power fields), six of 33 tumors had no mitotic figures per 50 HPF, 5 cases had 1-2 mitotic figures and 22 cases had > or = 3 mitotic figures. Histologically, 4 cases classified as benign, 4 cases as borderline and 25 cases as malignant. Follow-up of 7 cases with benign and borderline tumors were alive without tumor. In the malignant group of 23 cases, 6 patients died of disease, 10 patients were alive with evidence of metastatic disease, and 7 patients were alive without tumor. Immunohistochemically, 31 of 33 stromal tumors were positive for Ki67, 16 cases of malignant tumors showed significant staining (> 5% cells). 31 of 33 tumors were positive for p53 protein, and all the 25 (100%) malignant tumors showed staining. In 12 of the 25 cases, the staining was strong and diffuse(> 50% cells). When the Ki67 and p53 proteins were negative or showed focal expressions (Ki67 < 1% and p53 < 10%), the patients presented a good prognosis. And when there were strong expressions (Ki67 > 5% and p53 > 50%), the patients portended a poor prognosis.

CONCLUSION

Immunohistochemical analysis of Ki67 and p53 protein was a better method in the prognosis. When Ki67 showed strong position, it was a bad sign. When p53 protein showed strong position, it might be the potential malignant parameter. When Ki67 and p53 proteins were all strong expressions, these patients portended a poor prognosis. In addition to the invasion and metastasis, tumor size, mitotic counts and tumor cell necrosis were also helpful parameters for diagnosis of malignancy.

摘要

目的

通过观察小肠间质瘤(SBST)的免疫组化特征来探讨其预后的相关因素。

方法

对33例CD117表达阳性的间质瘤进行光镜检查。采用EnVision + 染色法检测肿瘤中Ki67和p53蛋白的表达,并与形态学进行比较。

结果

该组患者中男性20例,女性13例,年龄21至71岁(中位数:46岁);肿瘤位于十二指肠5例,空肠22例,回肠6例。大体上,肿瘤大小为1.5至20 cm。11例肿瘤有肿瘤细胞坏死灶。所有这些病例中,每50个高倍视野(HPF)的有丝分裂计数为0至62个有丝分裂象,33例肿瘤中有6例每50 HPF无有丝分裂象,5例有1至2个有丝分裂象,22例有≥3个有丝分裂象。组织学上,4例为良性,4例为交界性,25例为恶性。7例良性和交界性肿瘤患者随访时存活且无肿瘤。在23例恶性组中,6例患者死于疾病,10例患者存活但有转移证据,7例患者存活且无肿瘤。免疫组化方面,33例间质瘤中有31例Ki67阳性,16例恶性肿瘤显示明显染色(>5%细胞)。33例肿瘤中有31例p53蛋白阳性,所有25例(100%)恶性肿瘤均显示染色。25例中有12例染色强且弥漫(>50%细胞)。当Ki67和p53蛋白阴性或呈局灶性表达(Ki67<1%且p53<10%)时,患者预后良好。而当有强表达(Ki67>5%且p53>50%)时,患者预后不良。

结论

Ki67和p53蛋白的免疫组化分析是判断预后的较好方法。当Ki67呈强阳性时,是一个不良征象。当p53蛋白呈强阳性时,可能是潜在的恶性参数。当Ki67和p53蛋白均为强表达时,这些患者预后不良。除侵袭和转移外,肿瘤大小、有丝分裂计数和肿瘤细胞坏死也是诊断恶性肿瘤的有用参数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验